Interestingly, only when these NPs were targeted to the tumor draining lymph node, the CD4+ T-cell distribution within the tumor repolarized towards a TH1 phenotype and an increased frequency of therapeutic antigen-specific CD8+ T cells within the tumor was observed. This evidence concerns the gene CD4 and neoplasm.